NYSE American Approves InnSuites Compliance Plan, Extending Listing to 2027

Key Facts

1NYSE American accepted InnSuites Hospitality Trust's compliance plan, granting an extension for continued listing through December 24, 2027.

2The Trust confirmed that discussions regarding a reverse merger with Impact BioMedical are still ongoing.

In a move providing the company with critical time to address its regulatory standing, NYSE American has accepted InnSuites Hospitality Trust's (IHT) compliance plan. This approval grants the Trust an extension for its continued listing through December 24, 2027. The decision follows the formal submission of a compliance plan by the company on July 24, 2026, aimed at resolving existing listing deficiencies.

Alongside securing its exchange presence, the Trust confirmed that strategic discussions regarding a reverse merger with Impact BioMedical remain ongoing. According to market data, IHT shares closed at $1.34 (close September 14, 2026), having traded between a daily low of $1.25 and a high of $1.34 during that session.

Investors will be watching for further updates on the merger progress and the execution of the compliance milestones, with the stock positioned at $1.34 (close September 14, 2026). While the immediate delisting threat is removed, broader market sentiment remains influenced by recent macroeconomic data, such as the U.S. Producer Price Index figures released on September 10.